title: Dopamine modulates acetylcholine release via octopamine and CREB signaling in Caenorhabditis elegans.
abstract: Animals change their behavior and metabolism in response to external stimuli. cAMP response element binding protein (CREB) is a signal-activated transcription factor that enables the coupling of extracellular signals and gene expression to induce adaptive changes. Biogenic amine neurotransmitters regulate CREB and such regulation is important for long-term changes in various nervous system functions, including learning and drug addiction. In Caenorhabditis elegans, the amine neurotransmitter octopamine activates a CREB homolog, CRH-1, in cholinergic SIA neurons, whereas dopamine suppresses CREB activation by inhibiting octopamine signaling in response to food stimuli. However, the physiological role of this activation is unknown. In this study, the effect of dopamine, octopamine, and CREB on acetylcholine signaling was analyzed using the acetylcholinesterase inhibitor aldicarb. Mutants with decreased dopamine signaling exhibited reduced acetylcholine signaling, and octopamine and CREB functioned downstream of dopamine in this regulation. This study demonstrates that the regulation of CREB by amine neurotransmitters modulates acetylcholine release from the neurons of C. elegans.
authors: Department of Life Sciences, Graduate School of Arts & Sciences, University of Tokyo, Tokyo, Japan. suo@bio.c.u-tokyo.ac.jp
authors: Satoshi
authors: S
authors: Suo
authors: Shoichi
authors: S
authors: Ishiura
mesh_terms: D000109:Acetylcholine / Q000378:metabolism*; D000448:Aldicarb / Q000494:pharmacology; D000818:Animals; D017173:Caenorhabditis elegans / Q000187:drug effects / Q000235:genetics; D029742:Caenorhabditis elegans Proteins / Q000378:metabolism*; D059329:Cholinergic Neurons / Q000378:metabolism; D017362:Cyclic AMP Response Element-Binding Protein / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D017238:Genes, Helminth; D007978:Levamisole / Q000494:pharmacology; D009154:Mutation / Q000235:genetics; D009655:Octopamine / Q000378:metabolism*; D034622:RNA Interference / Q000187:drug effects; D015398:Signal Transduction / Q000187:drug effects; D013489:Suppression, Genetic / Q000187:drug effects; D014157:Transcription Factors / Q000378:metabolism*
chemical_list: C556191:CRH-1 protein, C elegans; D029742:Caenorhabditis elegans Proteins; D017362:Cyclic AMP Response Element-Binding Protein; D014157:Transcription Factors; D009655:Octopamine; D007978:Levamisole; D000448:Aldicarb; D000109:Acetylcholine; D004298:Dopamine
references: J Neurosci. 2006 Oct 4;26(40):10082-90
references: 17021164
references: Nat Rev Mol Cell Biol. 2001 Aug;2(8):599-609
references: 11483993
references: J Neurochem. 2011 Jan;116(1):1-9
references: 21044077
references: Genetics. 2011 Jul;188(3):579-90
references: 21515580
references: Am J Med Genet B Neuropsychiatr Genet. 2009 Jan 5;150B(1):12-23
references: 19035344
references: Trends Genet. 1999 Nov;15(11):463-70
references: 10529810
references: J Neurochem. 2003 Aug;86(4):869-78
references: 12887685
references: Mech Dev. 2001 Nov;109(1):27-35
references: 11677050
references: EMBO Rep. 2002 Oct;3(10):962-6
references: 12231504
references: Genetics. 1984 Feb;106(2):227-48
references: 6698395
references: J Neurosci. 2010 Dec 1;30(48):16365-75
references: 21123582
references: Cell. 1985 Mar;40(3):509-14
references: 3971421
references: Neuron. 2000 Jun;26(3):619-31
references: 10896158
references: Nature. 1995 May 4;375(6526):73-8
references: 7723846
references: Behav Neurosci. 2011 Aug;125(4):560-6
references: 21688885
references: Neuron. 1996 May;16(5):901-4
references: 8630246
references: Development. 1999 Dec;126(24):5819-31
references: 10572056
references: Nat Protoc. 2006;1(4):1772-7
references: 17487159
references: PLoS Biol. 2010 May 18;8(5):e1000372
references: 20502519
references: Gene. 2007 Jun 15;395(1-2):170-6
references: 17459615
references: EMBO Rep. 2011 Jul 08;12(8):855-62
references: 21738224
references: J Neurochem. 2005 Aug;94(4):1146-57
references: 16001968
references: J Neurosci. 1987 Oct;7(10):3059-71
references: 3668616
references: EMBO Rep. 2008 Jan;9(1):103-9
references: 17975555
references: J Neurosci Methods. 1999 Jul 1;89(1):33-40
references: 10476681
references: Nature. 2011 Feb 17;470(7334):404-8
references: 21331044
references: Prog Neurobiol. 1999 Dec;59(5):533-61
references: 10515667
references: Philos Trans R Soc Lond B Biol Sci. 1986 Nov 12;314(1165):1-340
references: 22462104
references: Genetics. 1974 May;77(1):71-94
references: 4366476
references: J Neurosci. 2007 Dec 19;27(51):14216-27
references: 18094261
references: J Comp Neurol. 1975 Sep 15;163(2):215-26
references: 240872
references: Nat Neurosci. 2004 Oct;7(10):1096-103
references: 15378064
references: Learn Mem. 2011 Sep 29;18(10):654-65
references: 21960709
references: EMBO J. 2009 Aug 19;28(16):2437-48
references: 19609300
references: Development. 2000 Aug;127(15):3361-71
references: 10887091
references: Neuron. 2005 Apr 21;46(2):247-60
references: 15848803